Bosh sahifaOGN • NYSE
add
Organon & Co
9,28 $
Seans yopilganidan keyin:(0,32%)-0,030
9,25 $
Yopilgan:17-okt, 19:45:43 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
9,38 $
Kunlik diapazon
9,14 $ - 9,40 $
Yillik diapazon
8,01 $ - 19,05 $
Bozor kapitalizatsiyasi
2,41 mlrd USD
Oʻrtacha hajm
3,65 mln
Narx/foyda
3,45
Dividend daromadliligi
0,86%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,59 mlrd | -0,81% |
Joriy xarajat | 548,00 mln | -0,90% |
Sof foyda | 145,00 mln | -25,64% |
Sof foyda marjasi | 9,10 | -24,98% |
Har bir ulushga tushum | 1,00 | -10,71% |
EBITDA | 425,00 mln | -5,97% |
Amaldagi soliq stavkasi | 36,68% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 599,00 mln | -14,91% |
Jami aktivlari | 13,50 mlrd | 11,07% |
Jami passivlari | 12,77 mlrd | 6,30% |
Umumiy kapital | 733,00 mln | — |
Tarqatilgan aksiyalar | 259,97 mln | — |
Narxi/balansdagi bahosi | 3,33 | — |
Aktivlardan daromad | 6,30% | — |
Kapitaldan daromad | 8,78% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 145,00 mln | -25,64% |
Operatsiyalardan naqd pul | 220,00 mln | -33,73% |
Sarmoyadan naqd pul | -38,00 mln | 17,39% |
Moliyadan naqd pul | -223,00 mln | -66,42% |
Naqd pulning sof oʻzgarishi | 52,00 mln | -59,69% |
Boʻsh pul | 91,12 mln | -60,79% |
Haqida
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Tashkil etilgan
1923
Sayt
Xodimlar soni
10 000
